Leading Customs Authorities Make The Case Against De Minimis Commerce
Leading customs authorities make the case against de minimis commerce By Charles Benoit, CPA Trade Counsel “De minimis” treatment for imports, which is available if
Leading customs authorities make the case against de minimis commerce By Charles Benoit, CPA Trade Counsel “De minimis” treatment for imports, which is available if
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senate Republicans, led by Mike Crapo, are willing to give the WTO more power over U.S. trade than the White House.
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
A bipartisan group of Republicans and Democrats support including the pro-China trade provision in the Senate USICA bill in the new Bipartisan Innovation Act.
An overvalued dollar is helping to exacerbate the country’s largest-ever trade deficit in goods. The U.S. is on pace for $1.1 trillion deficit in 2022.
Download CPA’s Legislative Alert here. OPPOSE TOOMEY MOTION TO INSTRUCT What’s happening: USICA’s trade provisions are a gift to China. It is far more than